YD Bio YDES
NASDAQ YDES
$4.93 -0.84 (-14.47%)
As of: Oct 22, 2026 · 12:05 PM EDT

YD Bio (YDES) Accumulated Expenses (2024 - 2026)

Updated

YD Bio's Accumulated Expenses came in at $132,424 for the quarter ended Jun 30, 2026.

Analysis

YD Bio (YDES) Accumulated Expenses (2024 - 2026) Analysis & Trends

As of Dec 31, 2025, YD Bio's Accumulated Expenses was $403,445.

  • Going back by year, Accumulated Expenses was $3,773 in the year ended Dec 31, 2024.
  • The figure for the quarter ended Jun 30, 2026 represents the lowest quarterly Accumulated Expenses since the quarter ended Dec 31, 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,170.99 Bn 1,139.58 Bn 19.71 Bn
2 Johnson & Johnson 642.25 Bn 560.77 Bn 17.26 Bn
3 AbbVie 502.08 Bn 475.19 Bn 12.70 Bn
4 Merck 375.61 Bn 329.99 Bn 12.21 Bn
5 Novartis Ag 302.76 Bn 266.75 Bn 11.24 Bn
6 Astrazeneca 268.66 Bn 242.35 Bn 12.86 Bn
7 Amgen 241.98 Bn 197.38 Bn 7.24 Bn
8 Gilead Sciences 193.37 Bn 167.57 Bn 6.22 Bn
9 Pfizer 172.42 Bn 119.07 Bn 10.94 Bn
10 YD Bio 329.26 Mn 316.99 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 132,424.00
Dec 31, 2025 403,445.00
Dec 31, 2024 3,773.00
API Access

YD Bio Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=YDES&period=max&api_key=YOUR_API_KEY